Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-30T15:02:44.855Z Has data issue: false hasContentIssue false
  • English
  • Français

Does rat fetal DNA induce preeclampsia in pregnant rats?

Published online by Cambridge University Press:  23 January 2015

B. Konečná ,
V. Borbélyová ,
P. Celec  and
B. Vlková
B. Konečná*
Affiliation:
Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
V. Borbélyová
Affiliation:
Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
P. Celec
Affiliation:
Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia Center of Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia Department of Molecular Biology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
B. Vlková
Affiliation:
Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia Center of Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia
*
*Address for correspondence: Barbora Vlková, MSc, PhD. Institute of Molecular Biomedicine Comenius University Sasinkova 4 811 08 Bratislava Slovakia. (Email [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Cell-free fetal DNA in maternal circulation is higher during preeclampsia. It is unclear whether it is the cause or the consequence of the disease. The aim of this study was to prove whether injected rat fetal DNA induces preeclampsia-like symptoms in pregnant Wistar rats. They received daily i.p. injections of water or rat fetal DNA (400 μg) from gestation day 14 to 18. Blood pressure, proteinuria, placental and fetal weight were measured at gestation day 19. Plasma DNase activity, proteinuria and creatinine clearance were assessed. There was no significant difference in any of the measured parameters. The results of this study do not confirm the hypothesis that fetal DNA might induce preeclampsia. This is in contrast to others using human fetal DNA in mice. Further studies should be focused on the effects of fetal DNA from the same species protected from DNase activity.

Keywords

extracellular DNAfetal DNAinnate immunitypreeclampsia
Type
Brief Report
Information
Journal of Developmental Origins of Health and Disease , Volume 6 , Issue 1 , February 2015 , pp. 5 - 9
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Vlkova, B, Szemes, T, Minarik, G, et al. Circulating free fetal nucleic acids in maternal plasma and preeclampsia. Medical Hypotheses. 2010; 74, 1030–1032.CrossRefGoogle ScholarPubMed
2.Kestlerova, A, Feyereisl, J, Frisova, V, et al. Immunological and biochemical markers in preeclampsia. J Reprod Immunol. 2012; 96, 90–94.CrossRefGoogle ScholarPubMed
3.Lo, YM, Corbetta, N, Chamberlain, PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350, 485–487.CrossRefGoogle ScholarPubMed
4.Lo, YM, Chiu, RW. Genomic analysis of fetal nucleic acids in maternal blood. Annu Rev Genomics Hum Genet. 2012; 285–306.CrossRefGoogle ScholarPubMed
5.Scharfe-Nugent, A, Corr, SC, Carpenter, SB, et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol. 2012; 188, 5706–5712.CrossRefGoogle ScholarPubMed
6.Yan, T, Cui, K, Huang, X, et al. Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats. Placenta. 2014; 35, 23–29.CrossRefGoogle ScholarPubMed
7.Yan, T, Liu, Y, Cui, K, et al. MicroRNA-126 regulates EPCs function: implications for a role of miR-126 in preeclampsia. J Cell Biochem. 2013; 114, 2148–2159.CrossRefGoogle ScholarPubMed
8.Watanabe, N, Kamei, S, Ohkubo, A, et al. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem. 1986; 32, 1551–1554.CrossRefGoogle Scholar
9.Malatyalioglu, E, Kurtoglu, E, Kokcu, E, et al. Systemic lupus erythematosus and pregnancy: a case report. J Obstet Gynaecol. 2014; 1–2.Google ScholarPubMed
10.Martin, A, Krishna, I, Martina, B, et al. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review. Prenat Diagn. 2014; 34, 685–691.CrossRefGoogle ScholarPubMed
11.McDonnold, M, Tamayo, E, Kechichian, T, et al. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol. 2014; 210, 542.e1–542.e7.CrossRefGoogle Scholar
12.Lin, Y, Liu, X, Shan, B, et al. Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells. PLoS One. 2014; 9, e94702.CrossRefGoogle ScholarPubMed
13.Orozco, AF, Jorgez, CJ, Horne, C, et al. Membrane protected apoptotic trophoblast microparticles contain nucleic acids relevance to preeclampsia. Am J Pathol. 2008; 173, 1595–1608.CrossRefGoogle ScholarPubMed